Leaderboards/Economic and Financial Impacts of Cancer

Economic and Financial Impacts of Cancer

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Angela N. Giaquinto
American Cancer Society
2
Mike Fillon
National Cancer Institute
3
Jingxuan Zhao
American Cancer Society
4
Luís Castelo-Branco
Spaulding Rehabilitation Hospital
5
Lauren V. Ghazal
University of Rochester
6
Huihui Yu
China Medical University
7
Ashley N. Wercholuk
The University of Texas Southwestern Medical Center
8
Ryan Huey
The University of Texas MD Anderson Cancer Center
9
November McGarvey
Health Outcomes Solutions (United States)
10
Whitney Victoria Johnson
University of Minnesota

Rising Stars Papers

1
Breast cancer statistics 2024
CA A Cancer Journal for Clinicians|2024
645 cit.
2
Incarceration History and Access to and Receipt of Health Care in the US
JAMA Health Forum|2024
36 cit.
3
Loneliness and Mortality Risk Among Cancer Survivors in the United States: A Retrospective, Longitudinal Study
Journal of the National Comprehensive Cancer Network|2024
27 cit.
4
Digital Protection and Inheritance Path of Intangible Cultural Heritage based on Image Processing Algorithm
Scalable Computing Practice and Experience|2024
11 cit.
5
Immune Checkpoint Inhibitors and Survival Disparities by Health Insurance Coverage Among Patients With Metastatic Cancer
JAMA Network Open|2025
9 cit.
6
Lobular breast cancer statistics, 2025
Cancer|2025
9 cit.
7
Cross‐sectional and longitudinal analysis of conditioned pain modulation and pain in fibromyalgia: CPM as an effect modifier of pain changes over time
Physiotherapy Research International|2024
8 cit.
8
County-level jail and state-level prison incarceration and cancer mortality in the United States
JNCI Journal of the National Cancer Institute|2024
8 cit.
9
Evaluation of a Conference on Cancer-Related Financial and Legal Issues: A Potential Resource to Counter Financial Toxicity
Current Oncology|2024
6 cit.
10
Deep learning accelerated micrograph-based porosity defect quantification in additively manufactured steels for uncovering a generic process-defect-properties relation
Materials Characterization|2025
6 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Thomas J. Littlejohns
University of Oxford
2
Yuri Fesko
Quest Diagnostics (United States)
3
Praveen Vikas
University of Iowa
4
André Ilbawi
World Health Organization
5
Jufang Shi
Shanghai Jiao Tong University
6
Anaeze C. Offodile
Memorial Sloan Kettering Cancer Center
7
Alexandru Eniu
Institute of Oncology Prof. Dr. Ion Chiricuta
8
Fumiko Chino
The University of Texas MD Anderson Cancer Center
9
Monica Bryant
Skin Cancer Foundation
10
Vincent Polkus
General Electric (United States)

Emerging Leaders Papers

1
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline
Journal of Clinical Oncology|2023
110 cit.
2
Association between metabolic syndrome and risk of incident dementia in UK Biobank
Alzheimer s & Dementia|2023
97 cit.
3
Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
JAMA Network Open|2022
83 cit.
4
Disaggregation of Asian American and Pacific Islander Women With Stage 0-II Breast Cancer Unmasks Disparities in Survival and Surgery-to-Radiation Intervals: A National Cancer Database Analysis From 2004 to 2017
JCO Oncology Practice|2022
59 cit.
5
Association Between Hospital Private Equity Acquisition and Outcomes of Acute Medical Conditions Among Medicare Beneficiaries
JAMA Network Open|2022
57 cit.
6
Area Deprivation Index is Associated with Variation in Quality of Life and Psychosocial Well-being Following Breast Cancer Surgery
Annals of Surgical Oncology|2022
53 cit.
7
The Patient Experience of Prior Authorization for Cancer Care
JAMA Network Open|2023
51 cit.
8
The long-term financial experiences of adolescent and young adult cancer survivors
Journal of Cancer Survivorship|2022
49 cit.
9
Area Deprivation Index and Rurality in Relation to Financial Toxicity among Breast Cancer Surgical Patients: Retrospective Cross-Sectional Study of Geospatial Differences in Risk Profiles
Journal of the American College of Surgeons|2022
39 cit.
10
Hypertension, a dementia polygenic risk score, <i>APOE</i> genotype, and incident dementia
Alzheimer s & Dementia|2022
35 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Ahmedin Jemal
American Cancer Society
2
Rebecca L. Siegel
American Cancer Society
3
Naomi E. Allen
University of Oxford
4
K. Robin Yabroff
American Cancer Society
5
Richard L. Schilsky
American Society of Clinical Oncology
6
Amy P. Abernethy
Parkland Health & Hospital System
7
Richard Sullivan
Precision Spine (United States)
8
David Cella
Northwestern University
9
S. Yousuf Zafar
Duke Medical Center
10
Toral Gathani
University of Oxford

Current Senior Leaders Papers

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2018
87.7k cit.
2
Global cancer statistics
CA A Cancer Journal for Clinicians|2011
55k cit.
3
Global cancer statistics, 2012
CA A Cancer Journal for Clinicians|2015
27.4k cit.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
23.1k cit.
5
Cancer statistics, 2020
CA A Cancer Journal for Clinicians|2020
21.4k cit.
6
Cancer statistics, 2019
CA A Cancer Journal for Clinicians|2019
21k cit.
7
Cancer statistics, 2022
CA A Cancer Journal for Clinicians|2022
18.2k cit.
8
Cancer Statistics, 2021
CA A Cancer Journal for Clinicians|2021
17.4k cit.
9
Cancer statistics, 2018
CA A Cancer Journal for Clinicians|2018
17k cit.
10
Cancer statistics, 2023
CA A Cancer Journal for Clinicians|2023
16.7k cit.

Reagents for Economic and Financial Impacts of Cancer

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

RocheEvidence 75

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

#760-5095 (also 08033706001)
View Evidence →
Cell Signaling TechnologyEvidence 63

Collagenase, Type 4

#44204$380
View Evidence →
Cell Signaling TechnologyEvidence 65

EGF Receptor (C74B9) Rabbit Monoclonal Antibody

#2646$156,345
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

VGLUT2 (D7D2H) Rabbit Monoclonal Antibody

Cited in 16 papers
#71555$161,351
View Evidence →
SignalwayEvidence 67

ERK 1/2 Polyclonal Antibody

#40903
View Evidence →
Cell Signaling TechnologyEvidence 68

ASC/TMS1 (D2W8U) Rabbit Monoclonal Antibody

#67824$151,351
View Evidence →